Cabaletta Bio shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a $40 price target.
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald has initiated coverage on Cabaletta Bio with an Overweight rating and a price target of $40. This has led to an increase in Cabaletta Bio's stock price.
October 24, 2023 | 3:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald's Overweight rating and $40 price target for Cabaletta Bio has led to a rise in the company's stock price.
Analyst ratings and price targets can significantly influence a company's stock price. In this case, Cantor Fitzgerald's Overweight rating and $40 price target for Cabaletta Bio has led to an increase in the company's stock price, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100